Intercellular Communication‐Driven Mitochondrial Transfer via CXCR4‐Engineered Macrophages Reprograms Bone Marrow Metabolism for Osteoporosis Therapy
Advanced Materials · 2026
DOI: 10.1002/adma.202521645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Di Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P. R. China. Hauptthemen laut MEDLINE: Mitochondria, Osteoporosis, Macrophages, Receptors, CXCR4. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 82400874, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Osteoporosis is characterized by impaired bone formation and disrupted bone marrow homeostasis, largely driven by mitochondrial dysfunction in bone marrow mesenchymal stem cells (BMSCs). To address this, a live mitochondrial delivery system composed of CXCR4‐engineered macrophages loaded with nanozyme‐functionalized mitochondria (CM‐MTBM). This system integrates bone‐targeted migration, reactive oxygen species scavenging, and communication‐mediated mitochondrial transfer. CM‐MTBM restores mitochondrial respiration, enhances osteogenic differentiation, and alleviates oxidative apoptosis in BMSCs, thereby promoting metabolic recovery and redox balance. In osteoporotic mice, CM‐MTBM treatment markedly improved the trabecular bone microarchitecture and promoted osteogenic repair. Single‐cell transcriptomic analysis further revealed the enrichment of osteogenic BMSC subpopulations and functional reprogramming of the bone marrow immune–metabolic microenvironment. Mechanistically, CM‐MTBM activated mitochondrial oxidative metabolism while suppressing inflammation and senescence‐associated signaling, achieving coordinated metabolic and osteogenic activation. Collectively, this work established a communication‐driven mitochondrial transfer paradigm that reframes mitochondrial therapy from passive structural supplementation to communication‐driven metabolic reprogramming, establishing a conceptual and technological framework for precision treatment of metabolic bone disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P. R. China.
- The Institute of Translational Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P. R. China.
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China.
ORCID-Profile: Da Zhong, Yizhe He, Jun Luo, Mingchuan Yu
Förderung
- National Natural Science Foundation of China
- 82400874
- Natural Science Foundation of Jiangxi Province
- Jiangxi Province Key Laboratory of Precision Cell Therapy
- Second Affiliated Hospital of Nanchang University
Zitieren
APA
Wang, D., Zhong, D., He, Y., Xie, J., Ruan, D., Liu, L., Tang, Z., Xie, W., Luo, J., & Yu, M. (2026). Intercellular Communication‐Driven Mitochondrial Transfer via CXCR4‐Engineered Macrophages Reprograms Bone Marrow Metabolism for Osteoporosis Therapy. Advanced Materials. https://doi.org/10.1002/adma.202521645
Vancouver
Wang D, Zhong D, He Y, Xie J, Ruan D, Liu L, et al. Intercellular Communication‐Driven Mitochondrial Transfer via CXCR4‐Engineered Macrophages Reprograms Bone Marrow Metabolism for Osteoporosis Therapy. Advanced Materials. 2026. doi:10.1002/adma.202521645
BibTeX
@article{Wang2026,
author = {Wang, Di and Zhong, Da and He, Yizhe and Xie, Jialiang and Ruan, Dong and Liu, Liwen and Tang, Zhibo and Xie, Weichang and Luo, Jun and Yu, Mingchuan},
title = {Intercellular Communication‐Driven Mitochondrial Transfer via CXCR4‐Engineered Macrophages Reprograms Bone Marrow Metabolism for Osteoporosis Therapy},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202521645}
}
EUVIMED